chr13-51974004-A-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000053.4(ATP7B):ā€‹c.1216T>Gā€‹(p.Ser406Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.471 in 1,614,028 control chromosomes in the GnomAD database, including 184,066 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S406T) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.40 ( 13523 hom., cov: 33)
Exomes š‘“: 0.48 ( 170543 hom. )

Consequence

ATP7B
NM_000053.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:20

Conservation

PhyloP100: -1.55
Variant links:
Genes affected
ATP7B (HGNC:870): (ATPase copper transporting beta) This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.1596646E-5).
BP6
Variant 13-51974004-A-C is Benign according to our data. Variant chr13-51974004-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 35701.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-51974004-A-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.524 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ATP7BNM_000053.4 linkuse as main transcriptc.1216T>G p.Ser406Ala missense_variant 2/21 ENST00000242839.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ATP7BENST00000242839.10 linkuse as main transcriptc.1216T>G p.Ser406Ala missense_variant 2/211 NM_000053.4 P1P35670-1

Frequencies

GnomAD3 genomes
AF:
0.401
AC:
60992
AN:
152042
Hom.:
13529
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.192
Gnomad AMI
AF:
0.377
Gnomad AMR
AF:
0.404
Gnomad ASJ
AF:
0.442
Gnomad EAS
AF:
0.541
Gnomad SAS
AF:
0.359
Gnomad FIN
AF:
0.538
Gnomad MID
AF:
0.475
Gnomad NFE
AF:
0.495
Gnomad OTH
AF:
0.455
GnomAD3 exomes
AF:
0.445
AC:
111028
AN:
249516
Hom.:
25851
AF XY:
0.446
AC XY:
60391
AN XY:
135366
show subpopulations
Gnomad AFR exome
AF:
0.184
Gnomad AMR exome
AF:
0.387
Gnomad ASJ exome
AF:
0.440
Gnomad EAS exome
AF:
0.533
Gnomad SAS exome
AF:
0.352
Gnomad FIN exome
AF:
0.545
Gnomad NFE exome
AF:
0.490
Gnomad OTH exome
AF:
0.471
GnomAD4 exome
AF:
0.478
AC:
698979
AN:
1461868
Hom.:
170543
Cov.:
73
AF XY:
0.476
AC XY:
345879
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
0.186
Gnomad4 AMR exome
AF:
0.391
Gnomad4 ASJ exome
AF:
0.439
Gnomad4 EAS exome
AF:
0.525
Gnomad4 SAS exome
AF:
0.350
Gnomad4 FIN exome
AF:
0.535
Gnomad4 NFE exome
AF:
0.497
Gnomad4 OTH exome
AF:
0.471
GnomAD4 genome
AF:
0.401
AC:
60988
AN:
152160
Hom.:
13523
Cov.:
33
AF XY:
0.404
AC XY:
30026
AN XY:
74388
show subpopulations
Gnomad4 AFR
AF:
0.192
Gnomad4 AMR
AF:
0.404
Gnomad4 ASJ
AF:
0.442
Gnomad4 EAS
AF:
0.540
Gnomad4 SAS
AF:
0.359
Gnomad4 FIN
AF:
0.538
Gnomad4 NFE
AF:
0.495
Gnomad4 OTH
AF:
0.454
Alfa
AF:
0.475
Hom.:
40907
Bravo
AF:
0.385
TwinsUK
AF:
0.494
AC:
1833
ALSPAC
AF:
0.508
AC:
1956
ESP6500AA
AF:
0.186
AC:
720
ESP6500EA
AF:
0.502
AC:
4158
ExAC
AF:
0.438
AC:
52986
Asia WGS
AF:
0.429
AC:
1489
AN:
3478
EpiCase
AF:
0.494
EpiControl
AF:
0.491

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:20
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:9
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 08, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 08, 2013- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 27, 2016- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Wilson disease Benign:9
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 18, 2011- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 05, 2018- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthFeb 05, 2024- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
not provided Uncertain:1Benign:1
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-multiple AR variants in same gene - keep for nowAllele frequency is common in at least one population database (frequency: 54.463% in ExAC) based on the frequency threshold of 2.434% for this gene.Variant was observed in a homozygous state in population databases more than expected for disease. -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 01, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
7.6
DANN
Uncertain
0.98
DEOGEN2
Benign
0.42
T;T;.;.;.;.;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.077
N
LIST_S2
Benign
0.22
T;T;T;T;T;T;T
MetaRNN
Benign
0.000042
T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N;.;N;.;.;.;.
MutationTaster
Benign
1.0
P;P;P;P;P;P;P
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.20
N;N;N;N;N;.;N
REVEL
Benign
0.049
Sift
Benign
0.75
T;T;T;T;T;.;T
Sift4G
Benign
0.77
T;T;T;T;T;T;T
Polyphen
0.0010
B;B;B;B;B;B;B
Vest4
0.018
MPC
0.053
ClinPred
0.0092
T
GERP RS
-0.027
Varity_R
0.051
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1801243; hg19: chr13-52548140; COSMIC: COSV54438507; COSMIC: COSV54438507; API